Literature DB >> 12729859

Stability of sufentanil and levobupivacaine solutions and a mixture in a 0.9% sodium chloride infusion stored in polypropylene syringes.

Annaliisa Jäppinen1, Miia Turpeinen, Hannu Kokki, Anu Rasi, Tarja Ojanen, Olavi Pelkonen, Toivo Naaranlahti.   

Abstract

We have evaluated the chemical and microbiological stability of sufentanil citrate, levobupivacaine hydrochloride and a mixture in a 0.9% sodium chloride infusion in order to provide background information on the storage of a sufentanil-levobupivacaine mixture in polypropylene (PP) syringes. Chemical assays were performed by HPLC on days 0, 1, 2, 3, 8, 14, 23, 28 and 30 after storage at 4, 21, and 36 degrees C. Microbiological stability was evaluated under aseptic conditions using a laminar air flow station, with a grade A environment and a B background. The samples taken for microbiological analysis were collected immediately after preparation of the solutions and then after 7, 14, 21 and 28 days storage. At 4 degrees C the sufentanil citrate solution was stable for 23 days. At 21 degrees C the sufentanil citrate solution maintained chemical stability for 3 days, but thereafter the concentration of sufentanil decreased 15% from day 3 to day 8. At 36 degrees C a similar decrease was noticed from day 1 to day 3. On the contrary, the levobupivacaine hydrochloride solution maintained chemical stability for 28 days at 4 and 21 degrees C and for 23 days at 36 degrees C. The sufentanil-levobupivacaine mixture maintained chemical stability for 28 days at 4, 21 and 36 degrees C. The sufentanil and levobupivacaine solutions and the mixture studied maintained microbiological stability for 28 days. According to the chemical and microbiological stability studies, the sufentanil-levobupivacaine mixture in PP syringes could be stored for 28 days at 4 and 21 degrees C.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12729859     DOI: 10.1016/s0928-0987(03)00041-1

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  5 in total

1.  Tramadol and hyoscine N-butyl bromide combined in infusion solutions: compatibility and stability.

Authors:  Emilia Barcia; Alicia Martín; María Luz Azuara; Yolanda Sánchez; Sofia Negro
Journal:  Support Care Cancer       Date:  2006-07-18       Impact factor: 3.603

Review 2.  Clinical Pharmacokinetics and Pharmacodynamics of Levobupivacaine.

Authors:  Chantal A A Heppolette; Derek Brunnen; Sohail Bampoe; Peter M Odor
Journal:  Clin Pharmacokinet       Date:  2020-06       Impact factor: 6.447

3.  A Mobile Device App to Reduce Time to Drug Delivery and Medication Errors During Simulated Pediatric Cardiopulmonary Resuscitation: A Randomized Controlled Trial.

Authors:  Johan N Siebert; Frederic Ehrler; Christophe Combescure; Laurence Lacroix; Kevin Haddad; Oliver Sanchez; Alain Gervaix; Christian Lovis; Sergio Manzano
Journal:  J Med Internet Res       Date:  2017-02-01       Impact factor: 5.428

4.  Therapeutic Treatment Plan Optimization during the COVID-19 Pandemic: A Comprehensive Physicochemical Compatibility Study of Intensive Care Units Selected Drugs.

Authors:  Maria Gloria Tarantini; Stéphanie Ramos; Philippe-Henri Secrétan; Laura Guichard; Lamia Hassani; Agnès Bellanger; Julien Mayaux; Patrick Tilleul; Fadwa El Kouari; Hassane Sadou Yayé
Journal:  Pharmaceutics       Date:  2022-02-28       Impact factor: 6.321

5.  [SBA 2020: Regional anesthesia safety recommendations update].

Authors:  Liana Maria Tôrres de Araújo Azi; Neuber Martins Fonseca; Livia Gurgel Linard
Journal:  Braz J Anesthesiol       Date:  2020-05-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.